AlphAIalphai — Financial news for AI agents
prnewswire.comAUG 191 min read$SY

So-Young to Report Second Quarter 2026 Financial Results on August 31, 2026

So-Young International Inc. (NASDAQ: SY) will release its Q2 2026 financial results on August 31, 2026, before U.S. market open. The company will host an earnings call at 7:30 AM ET, with a webcast and replay available. So-Young is a China-based aesthetic treatment platform connecting consumers with online and offline services.

Original reporting
prnewswire.com
Published Aug 19, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 10:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$SY
Neutral
medium confidence
Mentioned
$SY
Relevance
5/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$SYNeutralMed
01

Why it matters

The announcement sets the stage for a typical earnings‑driven trade, with no new financial data disclosed yet.

02

Market read

Earnings release date announcement provides a short‑term trading hook for SY and related sector stocks.

03

What to watch

Regulatory changes in Chinese healthcare or supply‑chain constraints could affect performance.

Relevance 5/10Novelty 5/10Timing: pre-market Aug 31 2026

Background

So-Young International Inc. (NASDAQ: SY) is a leading aesthetic treatment platform in China.

Company-level read

Ticker impact

$SYNeutralMedium confidence
Context

So-Young announced it will report Q2 2026 results on Aug 31, 2026 before US market open.

Expected impact

Potential modest move as investors position for earnings.

Evidence & confidence

No new financial numbers, but the timing of the release creates a trading opportunity.

Market effects

Sector

Aesthetic treatment sector may see heightened attention around earnings season.

Regional

China consumer discretionary stocks could be influenced by So-Young's results.

Global

Limited to investors tracking US-listed Chinese consumer stocks.

Counterpoint

What could challenge this read

If earnings miss expectations, the stock could sharply decline despite pre‑earnings optimism.

Key entities

  • company
    So-Young International Inc.

    NASDAQ‑listed Chinese aesthetic treatment platform.

Read at source← All news

Related articles

AUG 31
$SYMedAI 8/10

So-Young International Q2 Earnings Call Highlights

So-Young International reported Q2 earnings, highlighting 52% same-store sales growth and improved unit-level profitability. Aesthetic treatment revenue grew, while other segments declined. Gross margin increased to 28.1%. The company expects Q3 aesthetic revenue of RMB352M-RMB362M, up 91.7%-97.2% YoY. Management plans to focus on clinic growth and reduce investment in loss-making businesses.

yahoo.com6 min
AUG 31
$SYMed

So-Young International Inc. (SY): Financial results for Q2 2026

So-Young International Inc. (SY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 So-Young Reports Unaudited Second Quarter 2026 Financial Results BEIJING, China , August 31, 2026 — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the leading aesthetic treatment platform in China connecting consumers with online services and

SEC EDGAR 6-K2 min
AUG 31
$SYMed

So-Young Reports Unaudited Second Quarter 2026 Financial Results

So-Young International Inc. (SY) reported Q2 2026 revenues of RMB505.2 million (US$74.5 million), up 33.4% YoY. Aesthetic treatment services revenue surged 129.5% YoY to RMB331.4 million (US$48.8 million). Net loss narrowed to RMB22.7 million (US$3.3 million) from RMB36.0 million YoY. Active users and treatment visits also increased significantly. The company operates 65 branded aesthetic centers, with 47 profitable and 51 generating positive cash flow. Management highlighted strong execution an

prnewswire.com2 min
SEP 2
$NKEMedAI 8/10

Nike Stock Is Down 78% From Its All

Nike (NKE) expects gross margins to expand in Q1 2027, though revenue may stay pressured due to reduced discounting. Sales fell 1% in fiscal 2026, but margins improved to 49.2%. The stock is down 78% from its 2021 high, trading at 23x fiscal 2027 earnings estimates, with analysts forecasting $2.71B in earnings by fiscal 2029.

aol.com3 min